Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Monitoring OKT3 treatment: pharmacodynamic and pharmacokinetic measures.

× No keyword cloud information.

6 in total

1. Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts.

Authors: Jing Li; Bo Zhou; Jianzhong Shentu; Li Du; Min Tan; Sheng Hou; Weizhu Qian; Bohua Li; Dapeng Zhang; Jianxin Dai; Hao Wang; Xu Zhang; Jianghua Chen; Yajun Guo
Journal: MAbs Date: 2010-07-01 Impact factor: 5.857

Review 2. The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors: S M Tsunoda; F T Aweeka
Journal: Clin Pharmacokinet Date: 1996-02 Impact factor: 6.447

Review 3. Immunosuppressant-induced nephropathy: pathophysiology, incidence and management.

Authors: A J Olyaei; A M de Mattos; W M Bennett
Journal: Drug Saf Date: 1999-12 Impact factor: 5.606

Review 4. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.

Authors: M I Wilde; K L Goa
Journal: Drugs Date: 1996-05 Impact factor: 9.546

5. OKT3 monitoring in the treatment of steroid-resistant acute rejection of hepatotransplant recipients.

Authors: P Brusa; R Casullo; F Dosio; L Cattel; S Beltramini; R Chiappetta; L Tosetti; E Andorno; M Salizzoni
Journal: Eur J Drug Metab Pharmacokinet Date: 1998 Apr-Jun Impact factor: 2.441

6. TGN1412 Induces Lymphopenia and Human Cytokine Release in a Humanized Mouse Model.

Authors: Sabrina Weißmüller; Stefanie Kronhart; Dorothea Kreuz; Barbara Schnierle; Ulrich Kalinke; Jörg Kirberg; Kay-Martin Hanschmann; Zoe Waibler
Journal: PLoS One Date: 2016-03-09 Impact factor: 3.240

6 in total